GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (TSE:4967) » Definitions » Equity-to-Asset

Kobayashi Pharmaceutical Co (TSE:4967) Equity-to-Asset : 0.77 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Kobayashi Pharmaceutical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kobayashi Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was 円204,816 Mil. Kobayashi Pharmaceutical Co's Total Assets for the quarter that ended in Dec. 2023 was 円267,473 Mil. Therefore, Kobayashi Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.77.

The historical rank and industry rank for Kobayashi Pharmaceutical Co's Equity-to-Asset or its related term are showing as below:

TSE:4967' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.7   Med: 0.75   Max: 0.77
Current: 0.77

During the past 13 years, the highest Equity to Asset Ratio of Kobayashi Pharmaceutical Co was 0.77. The lowest was 0.70. And the median was 0.75.

TSE:4967's Equity-to-Asset is ranked better than
82.43% of 1918 companies
in the Consumer Packaged Goods industry
Industry Median: 0.54 vs TSE:4967: 0.77

Kobayashi Pharmaceutical Co Equity-to-Asset Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Equity-to-Asset Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 0.77 0.77 0.77 0.77

Kobayashi Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.79 0.78 0.79 0.77

Competitive Comparison of Kobayashi Pharmaceutical Co's Equity-to-Asset

For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kobayashi Pharmaceutical Co's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Kobayashi Pharmaceutical Co's Equity-to-Asset falls into.



Kobayashi Pharmaceutical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Kobayashi Pharmaceutical Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=204816/267473
=0.77

Kobayashi Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=204816/267473
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kobayashi Pharmaceutical Co  (TSE:4967) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Kobayashi Pharmaceutical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Kobayashi Pharmaceutical Co (TSE:4967) Business Description

Traded in Other Exchanges
Address
KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co (TSE:4967) Headlines

No Headlines